bioRxivMicrobiology
Pseudohyphal growth of the emerging pathogen Candida auris is triggered by genotoxic stress through the S phase checkpoint
Abstract
The morphogenetic switching between yeast cells and filaments (true hyphae and pseudohyphae) is a key cellular feature required for full virulence in many polymorphic fungal pathogens, such as Candida albicans. In the recently emerged yeast pathogen Candida auris, occasional elongation of cells has been reported. However, environmental conditions and genetic triggers for filament formation have remained elusive. Here, we report that induction of DNA damage and perturbation of replication forks by treatment with genotoxins, such as hydroxyurea, methyl methanesulfonate, and the clinically relevant fungistatic 5-fluorocytosine, causes filamentation in C. auris. The filaments formed were characteristic of pseudohyphae and not parallel-sided true hyphae. Pseudohyphal growth is apparently signalled through the S phase checkpoint and, interestingly, is Tup1-independent in C. auris. Intriguingly, the morphogenetic switching capability is strain-specific in C. auris, highlighting the heterogenous nature of the species as a whole.\n\nIMPORTANCECandida auris is a newly emerged fungal pathogen of humans. This species was first reported in 2009, when it was identified in an ear infection of a patient in Japan. However, despite intense interest in this organism as an often multidrug-resistant fungus there is little knowledge about its cellular biology. During infection of human patients, fungi are able to change cell shape from ellipsoidal yeast cells to elongated filaments to adapt to various conditions within the host organism. There are different types of filaments, which are triggered by reactions to different cues. Candida auris fails to form filaments when exposed to triggers that stimulate yeast-filament morphogenesis in other fungi. Here, we show that it does form filaments when its DNA is damaged. These conditions might arise when Candida auris cells interact with host immune cells, or growing in certain host tissues (kidney, bladder), or during treatment with antifungal drugs.
- organism: C. elegans
- research focus: host-pathogen & immune response
- research focus: cell signaling & trafficking
- research focus: development & morphogenesis
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Forward and Reverse Genetic Dissection of Morphogenesis Identifies Filament-Competent Candida auris Strains
D. J. Santana, T. R. O'Meara·bioRxiv·Apr 29, 2021
- Melanization of Candida auris is Associated with Alteration of Extracellular pH
D. F. Q. Smith, N. J. Mudrak, … A. Casadevall·bioRxiv·Jul 14, 2022
- Candida auris phenotypic heterogeneity determines pathogenicity in vitro
J. L. Brown, C. Delaney, … G. Ramage·mSpherePeer-reviewed·Jun 24, 2020
- Growth phase influences virulence in Candidozyma auris systemic infection models
Michael J. McFadden, Juliet A. E. Anku, … Teresa R. O’Meara·mSpherePeer-reviewed·Dec 5, 2025
- Candida auris can acquire antifungal resistance without selection pressure
Trinh Phan-Canh, Duc-Minh Nguyen-Le, … Karl Kuchler·bioRxiv·Jan 8, 2026
- The emerging fungal pathogen Candida auris induces IFNγ to colonize mammalian hair follicles
Eric Dean Merrill, Victoria Prudent, … Suzanne M. Noble·bioRxiv·Jan 15, 2025